AID TB resistance line probe assay for rapid detection of resistant Mycobacterium tuberculosis in clinical samples

Journal of Infection

Volumn 70, Issue 4, 2015, Pages 400-408

  Molina Moya, B ^a,b   Lacoma, A ^a,b   Prat, C ^a,b   Diaz, J ^a   Dudnyk, A ^f   Haba, L ^a   Maldonado, J ^c   Samper, S ^b,d,e   Ruiz Manzano, J ^a,b   Ausina, V ^a,b   Dominguez, J ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Hospital Serveis Clinics   (Spain)

^d INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^e HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^f NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

Extensively drug resistant tuberculosis; Molecular diagnostic testing; Multi drug resistance; Tuberculosis

Indexed keywords

AMIKACIN; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

AID TB RESISTANCE LINE PROBE ASSAY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG RESISTANT TUBERCULOSIS; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; NONHUMAN; PYROSEQUENCING; RAPID TEST; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; TEST STRIP; DRUG EFFECTS; ISOLATION AND PURIFICATION; LUNG LAVAGE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; SPUTUM; STANDARD; TUBERCULOSIS, MULTIDRUG-RESISTANT;

BRONCHOALVEOLAR LAVAGE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84926133934     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.09.010     Document Type: Article

References (51)

1. World Health Organization Global tuberculosis control 2013, (WHO/HTM/TB/2013.11). Geneva Switzerland.
2. Cox H.S., Sibilia K., Feuerriegel S., Kalon S., Polonsky J., Khamraev A.K., et al. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis. N Engl J Med 2008 Nov 27, 359(22):2398-2400. PubMed PMID: 19038891.
3. Gandhi N.R., Nunn P., Dheda K., Schaaf H.S., Zignol M., van Soolingen D., et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010 May 22, 375(9728):1830-1843. PubMed PMID: 20488523.
4. Lange C., Abubakar I., Alffenaar J.W., Bothamley G., Caminero J.A., Carvalho A.C., et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J 2014 Jul, 44(1):23-63. PubMed PMID: 24659544. Pubmed Central PMCID: 4076529.
5. Almeida Da Silva P.E., Palomino J.C. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J Antimicrob Chemother 2011 Jul, 66(7):1417-1430. PubMed PMID: 21558086.
6. Zhang Y., Yew W.W. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009 Nov, 13(11):1320-1330. PubMed PMID: 19861002.
7. Richter E., Rusch-Gerdes S., Hillemann D. Drug-susceptibility testing in TB: current status and future prospects. Expert Rev Respir Med 2009 Oct, 3(5):497-510. PubMed PMID: 20477339.
8. Telenti A., Honore N., Bernasconi C., March J., Ortega A., Heym B., et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997 Mar, 35(3):719-723. PubMed PMID: 9041419.
9. Herrera L., Jimenez S., Valverde A., Garcia-Aranda M.A., Saez-Nieto J.A. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents 2003 May, 21(5):403-408. PubMed PMID: 12727071.
10. Telenti A., Imboden P., Marchesi F., Lowrie D., Cole S., Colston M.J., et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993 Mar 13, 341(8846):647-650. PubMed PMID: 8095569.
11. Honore N., Cole S.T. Streptomycin resistance in mycobacteria. Antimicrob Agents Chemother 1994 Feb, 38(2):238-242. PubMed PMID: 8192450.
12. Plinke C., Rusch-Gerdes S., Niemann S. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2006 May, 50(5):1900-1902. PubMed PMID: 16641474.
13. Telenti A., Philipp W.J., Sreevatsan S., Bernasconi C., Stockbauer K.E., Wieles B., et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 1997 May, 3(5):567-570. PubMed PMID: 9142129.
14. Finken M., Kirschner P., Meier A., Wrede A., Bottger E.C. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol 1993 Sep, 9(6):1239-1246. PubMed PMID: 7934937.
15. Ramaswamy S., Musser J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998, 79(1):3-29. PubMed PMID: 10645439.
16. Maruri F., Sterling T.R., Kaiga A.W., Blackman A., van der Heijden Y.F., Mayer C., et al. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J Antimicrob Chemother 2012 Apr, 67(4):819-831. PubMed PMID: 22279180.
17. Takiff H.E., Salazar L., Guerrero C., Philipp W., Huang W.M., Kreiswirth B., et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 1994 Apr, 38(4):773-780. PubMed PMID: 8031045.
18. Maus C.E., Plikaytis B.B., Shinnick T.M. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005 Aug, 49(8):3192-3197. PubMed PMID: 16048924.
19. Alangaden G.J., Kreiswirth B.N., Aouad A., Khetarpal M., Igno F.R., Moghazeh S.L., et al. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1998 May, 42(5):1295-1297. PubMed PMID: 9593173.
20. Zaunbrecher M.A., Sikes R.D., Metchock B., Shinnick T.M., Posey J.E. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2009 Nov 24, 106(47):20004-20009. PubMed PMID: 19906990.
21. Wilson M.L. Rapid diagnosis of Mycobacterium tuberculosis infection and drug susceptibility testing. Arch Pathol Lab Med 2013 Jun, 137(6):812-819. PubMed PMID: 23721277.
22. World Health Organization Policy statement. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB) 2008, Geneva Switzerland.
23. Kent P.T.K., G.P Public health mycobacteriology-a guide for the level III laboratory 1985, U.S. Department of Health and Human Services, U.S. Government Printing Office, Washington, D.C., Atlanta, GA.
24. Isenberg H.D. Clinical microbiology procedures handbook 2007, 4300. ASM Press, Washington. 2nd update ed. H.D. Isenberg (Ed.).
25. Tessema B., Beer J., Emmrich F., Sack U., Rodloff A.C. Rate of recovery of Mycobacterium tuberculosis from frozen acid-fast-bacillus smear-positive sputum samples subjected to long-term storage in Northwest Ethiopia. J Clin Microbiol 2011 Jul, 49(7):2557-2561. PubMed PMID: 21562105.
26. Garcia-Sierra N., Lacoma A., Prat C., Haba L., Maldonado J., Ruiz-Manzano J., et al. Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2011 Oct, 49(10):3683-3686.
27. Lacoma A., Garcia-Sierra N., Prat C., Maldonado J., Ruiz-Manzano J., Haba L., et al. GenoType MTBDRsl for molecular detection of second-line and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol 2012 Nov 9, 50(1):30-36. PubMed PMID: 22075597.
28. Lacoma A., Garcia-Sierra N., Prat C., Ruiz-Manzano J., Haba L., Roses S., et al. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol 2008 Nov, 46(11):3660-3667. PubMed PMID: 18784319.
29. Barnard M., Albert H., Coetzee G., O'Brien R., Bosman M.E. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008 Apr 1, 177(7):787-792. PubMed PMID: 18202343.
30. Causse M., Ruiz P., Gutierrez J.B., Zerolo J., Casal M. Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2008 Dec, 12(12):1456-1460. PubMed PMID: 19017457.
31. Hillemann D., Rusch-Gerdes S., Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007 Aug, 45(8):2635-2640. PubMed PMID: 17537937.
32. Miotto P., Cabibbe A.M., Mantegani P., Borroni E., Fattorini L., Tortoli E., et al. GenoType MTBDRsl performance on clinical samples with diverse genetic background. Eur Respir J 2012 Sep, 40(3):690-698. PubMed PMID: 22267773.
33. Hillemann D., Rusch-Gerdes S., Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2009 Jun, 47(6):1767-1772. PubMed PMID: 19386845.
34. Dorman S.E., Chihota V.N., Lewis J.J., van der Meulen M., Mathema B., Beylis N., et al. Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa. J Clin Microbiol 2012 Apr, 50(4):1189-1194. PubMed PMID: 22238443.
35. Lyu J., Kim M.N., Song J.W., Choi C.M., Oh Y.M., Lee S.D., et al. GenoType(R) MTBDRplus assay detection of drug-resistant tuberculosis in routine practice in Korea. Int J Tuberc Lung Dis 2013 Jan, 17(1):120-124. PubMed PMID: 23232012.
36. Feuerriegel S., Oberhauser B., George A.G., Dafae F., Richter E., Rusch-Gerdes S., et al. Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting. BMC Microbiol 2012, 12:90. PubMed PMID: 22646308.
37. Bwanga F., Hoffner S., Haile M., Joloba M.L. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009, 9:67. PubMed PMID: 19457256.
38. Heep M., Brandstatter B., Rieger U., Lehn N., Richter E., Rusch-Gerdes S., et al. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2001 Jan, 39(1):107-110. PubMed PMID: 11136757.
39. Barnard M., Warren R., Van Pittius N.G., van Helden P., Bosman M., Streicher E., et al. Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory. Am J Respir Crit Care Med 2012 Dec 15, 186(12):1298-1305. PubMed PMID: 23087027.
40. Ajbani K., Nikam C., Kazi M., Gray C., Boehme C., Balan K., et al. Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments. PLoS One 2012, 7(11):e49433. PubMed PMID: 23166667.
41. Tukvadze N., Bablishvili N., Apsindzelashvili R., Blumberg H.M., Kempker R.R. Performance of the MTBDRsl assay in Georgia. Int J Tuberc Lung Dis 2014 Feb, 18(2):233-239. PubMed PMID: 24429319.
42. Feng Y., Liu S., Wang Q., Wang L., Tang S., Wang J., et al. Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis. PLoS One 2013, 8(2):e55292. PubMed PMID: 23383320.
43. Ramaswamy S.V., Amin A.G., Goksel S., Stager C.E., Dou S.J., El Sahly H., et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000 Feb, 44(2):326-336. PubMed PMID: 10639358.
44. Jin J., Shen Y., Fan X., Diao N., Wang F., Wang S., et al. Underestimation of the resistance of Mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test. J Mol Diagn 2013 Jan, 15(1):44-50. PubMed PMID: 23159109.
45. Moure R., Tudo G., Medina R., Vicente E., Caldito J.M., Codina M.G., et al. Detection of streptomycin and quinolone resistance in Mycobacterium tuberculosis by a low-density DNA array. Tuberc (Edinb) 2013 Sep, 93(5):508-514. PubMed PMID: 23906937.
46. Lee A.S., Ong D.C., Wong J.C., Siu G.K., Yam W.C. High-resolution melting analysis for the rapid detection of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosis. PLoS One 2012, 7(2):e31934. PubMed PMID: 22363772.
47. Jnawali H.N., Hwang S.C., Park Y.K., Kim H., Lee Y.S., Chung G.T., et al. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. Diagn Microbiol Infect Dis 2013 Jun, 76(2):187-196. PubMed PMID: 23561273.
48. Tudo G., Rey E., Borrell S., Alcaide F., Codina G., Coll P., et al. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona. J Antimicrob Chemother 2010 Nov, 65(11):2341-2346. PubMed PMID: 20802233.
49. Tracevska T., Jansone I., Nodieva A., Marga O., Skenders G., Baumanis V. Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. Res Microbiol 2004 Dec, 155(10):830-834. PubMed PMID: 15567277.
50. World Health Organization Policy Statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance 2011, XpertMTB/RIF system. (WHO/HTM/TB2011.4). Geneva, Switzerland.
51. Ritter C., Lucke K., Sirgel F.A., Warren R.W., van Helden P.D., Bottger E.C., et al. Evaluation of the AID TB resistance line probe assay for rapid detection of genetic alterations associated with drug resistance in Mycobacterium tuberculosis strains. J Clin Microbiol 2014 Jan 8, 52(3):940-946. PubMed PMID: 24403306.